Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04603495
Title Study of CPI-0610 in Myelofibrosis (MF) (MANIFEST-2)
Acronym MANIFEST-2
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Constellation Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | POL | NLD | ITA | ISR | HUN | GRC | GBR | FRA | ESP | DEU | CZE | CAN | BEL | AUT | AUS


No variant requirements are available.